Ignite Creation Date:
2025-12-24 @ 1:17 PM
Ignite Modification Date:
2026-02-01 @ 7:08 PM
Study NCT ID:
NCT05672095
Status:
WITHDRAWN
Last Update Posted:
2025-05-23
First Post:
2023-01-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Niraparib and Selenium for the Treatment of Recurrent BRCA Negative Platinum Resistant Ovarian Cancer
Sponsor:
City of Hope Medical Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Platinum-Resistant Fallopian Tube Carcinoma | View |
| None | Platinum-Resistant Ovarian Carcinoma | View |
| None | Platinum-Resistant Primary Peritoneal Carcinoma | View |
| None | Recurrent Fallopian Tube Carcinoma | View |
| None | Recurrent Ovarian Carcinoma | View |
| None | Recurrent Primary Peritoneal Carcinoma | View |
Keywords: